FDA Inspection 1227030 — Nationwide Childrens Hospital Transfusion Service
The FDA completed an inspection of Nationwide Childrens Hospital Transfusion Service on Jan 2, 2024 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 2, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbus, OH (United States)